GL1X · GenesisL1 explorer

Research workbench

Crystal structure of BCL-2 in complex with the novel orally active inhibitor S55746

Analyse Crystal structure of BCL-2 in complex with the novel orally active inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6GL8
Type
protein
Length
144 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Apoptosis regulator BCL-2,APOPTOSIS regulator BCL-2, apoptosis regulator BCL-2,BCL-2-like…
UniProt
P10415
Ligands
F3Q
Pockets
1 · best druggability 0.40

Structure

x-ray diffraction · 1 distinct chain · 78% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AApoptosis regulator BCL-2,APOPTOSIS regulator BCL-2, apoptosis regulator BCL-2,BCL-2-like protein 1,APOPTOSIS regulator BCL-2,APOPTOSIS regulator BCL-2,APOPTOSIS regulator BCL-2protein14478% helix, 0% strandP10415

Ligands and binding sites

  • F3Q · ~{N}-(4-hydroxyphenyl)-3-[6-[[(3~{S})-3-(morpholin-4-ylmethyl)-3,4-dihydro-1~{H}-isoquinolin-2-yl]carbonyl]-1,3-benzodioxol-5-yl]-~{N}-phenyl-5,6,7, 8-tetrahydroindolizine-1-carboxamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.400.7513F3Q

Compared structures

  • 6GL8 · Crystal structure of Bcl-2 in complex with the novel orally active inhibitor S55746 · the same entry in another collection · chain A against A, TM-score 1.00
  • P10415 · AlphaFold monomer V2.0 prediction for apoptosis regulator BCL-2 (P10415) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.